Press Releases

Press Releases

Date Title and Summary Additional Formats
Toggle Summary EDAP to Host Meetings with Investors During JP Morgan Healthcare Conference Week
LYON, France , Jan. 04, 2017 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced that it will be hosting meetings with analysts and investors during the JP Morgan Healthcare conference week, January 9th & 10th in San Francisco, CA.
View HTML
Toggle Summary EDAP Reports Superior Outcomes of Focal Ablatherm-HIFU Compared to Robotic Radical Prostatectomy
Similar Cancer Control at 5 Years, Significantly Less Incidence of Incontinence and Erectile Dysfunction
View HTML
Toggle Summary EDAP Announces Focal One® HIFU Sale to Foch Hospital, Paris
Growing Adoption of Focal One HIFU in France
View HTML
Toggle Summary EDAP TMS Retains CG Capital as New Investor Relations Counsel
LYON, France , Dec. 12, 2016 (GLOBE NEWSWIRE) -- EDAP TMS S.A. (NASDAQ:EDAP), the global leader in therapeutic ultrasound today announced that it has retained CG Capital , a leading capital markets development and research firm as their new investor relations counsel.
View HTML
Toggle Summary EDAP Receives the Prestigious Prix Galien for its Focal One® HIFU device
LYON, France , Dec. 08, 2016 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced the award of the prestigious 2016 Prix Galien, in the Medical Device category, for its Focal One HIFU device dedicated to the treatment of localized prostate
View HTML
Toggle Summary EDAP Achieves 79% Growth in HIFU Revenue for First Nine Months of 2016
Highlights at the end of September 30, 2016 : Total cumulated revenue in 2016  up 22% year-over-year; Driven by HIFU growth, Gross Margin increases to 45%; 111% growth in HIFU revenues in Q3 of 2016 compared to Q3 2015; Company continues to show operating profit in 2016 at the end of Q3; Strong
View HTML
Toggle Summary EDAP to Report Third Quarter 2016 Financial Results on November 17, 2016
Conference Call and Webcast Scheduled for 8:30 a.m. ET
View HTML
Toggle Summary EDAP‘s Ablatherm® Robotic HIFU Positioned as Efficient Option for Unilateral Prostate Ablation in Breakthrough Multicenter Study Published in Major Medical Journal
LYON, France , Oct. 11, 2016 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced the results of a multicentric study using Ablatherm Robotic HIFU which demonstrates promising oncologic outcomes with low side effects.
View HTML
Toggle Summary EDAP Installs Ablatherm Robotic® HIFU at Leading Academic Medical Center
LYON, France , Sept. 12, 2016 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced the signature of a contract for the installation of Ablatherm Robotic HIFU at the renowned Duke University Hospital located in Durham, North Carolina .
View HTML
Toggle Summary EDAP TMS to Present at the 18th Annual Rodman and Renshaw Global Investment Conference
LYON, France , Sept. 06, 2016 (GLOBE NEWSWIRE) -- EDAP TMS SA  (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced that Marc Oczachowski , Chief Executive Officer of EDAP TMS , is scheduled to present at the 18 th Annual Rodman & Renshaw Global Investment Conference being
View HTML